8-K/A: Cosmos Health Inc. Dismisses KPMG, Appoints New Auditor Amidst Disagreement Over Audit Findings

Cosmos Health Inc. replaced its auditor, KPMG, with RBSM LLP following a dispute over accounting practices and the handling of a third-party consignment vendor transaction.

Summary

• Cosmos Health Inc. dismissed KPMG as its independent auditor on April 26, 2024, due to KPMG's inability to complete the 2023 audit on time.
• The company's Audit Committee voted to dismiss KPMG, and the Board of Directors agreed with this decision.
• KPMG stated there were disagreements over accounting principles, financial disclosures, and auditing scope, specifically regarding a third-party consignment vendor transaction.
• KPMG claimed they identified a potential illegal act related to the transaction and requested an investigation, which they say was not initiated.
• Cosmos Health disputes KPMG's claims, stating that KPMG only raised concerns about the inventory account and related transactions, not an illegal act.
• An independent inventory count was conducted on April 30, 2024, which the company says substantiated the transaction in question.
• RBSM LLP was appointed as the new independent auditor on April 29, 2024, to audit the 2023 financial statements.

Sentiment

Score: 3

Explanation: The document reveals significant issues including auditor dismissal, disagreements over accounting practices, potential illegal acts, and missed filing deadlines, all of which are negative indicators for investors.

Positives

• Cosmos Health took prompt action by conducting an independent inventory count on April 30, 2024, to address concerns raised by KPMG.
• The company engaged a new auditor, RBSM LLP, quickly on April 29, 2024, to ensure the audit process could continue.

Negatives

• KPMG was unable to complete the audit of the company's financial statements for the year ended December 31, 2023, on a timely basis.
• There were disagreements between Cosmos Health and KPMG regarding accounting principles, financial disclosures, and auditing scope.
• KPMG raised concerns about a potential illegal act related to a third-party consignment vendor transaction.
• The company missed its March 31, 2024, and subsequently the extended April 15, 2024, deadline to file Form 10-K, which could lead to delisting from NASDAQ.

Risks

• The disagreement with KPMG and the delay in filing the Form 10-K could negatively impact investor confidence.
• The potential delisting from NASDAQ due to the missed filing deadline poses a significant risk to the company.
• The concerns raised by KPMG about a potential illegal act, even if disputed by Cosmos Health, could lead to further scrutiny and investigation.
• The transition to a new auditor, RBSM LLP, may present challenges and require additional time and resources.

Future Outlook

The company needs to complete its 2023 audit with RBSM LLP and file its Form 10-K to avoid potential delisting from NASDAQ.

Management Comments

• The Companys Audit Committee, mindful of certain filing deadlines under the US securities laws, unanimously voted in favor to dismiss KPMG as the Companys independent auditors.
• The Company objects to such statements made by KPMG and provides a response letter.
• Contrary to KMPGs assertions, KPMG never informed the Companys Audit Committee that an illegal act may have occurred.
• The Company has taken prompt actions in regard to such inquiry and, on April 30, 2024, the independent inventory count was conducted.
• In light of KPMG's audit role and the regular updates and communications between KPMG and the Company, the Company views your letter as factually inaccurate.

Industry Context

The change of auditors and the disagreement over accounting practices are not uncommon in the industry, but the potential for delisting due to missed deadlines is a serious concern. This situation highlights the importance of timely and accurate financial reporting and the need for a strong relationship between companies and their auditors.

Comparison to Industry Standards

• The dismissal of an auditor due to disagreements is not unusual, but the severity of the issues raised by KPMG, including the suggestion of a potential illegal act, is concerning.
• Companies like Enron and WorldCom faced similar auditor disagreements and accounting issues, which led to significant financial and legal consequences.
• The delay in filing the Form 10-K is a significant deviation from industry standards, as most public companies adhere to strict SEC deadlines.
• The appointment of a new auditor, RBSM LLP, is a standard practice when an auditor is dismissed, but the transition period can be challenging and may impact the timeline for financial reporting.

Stakeholder Impact

• Shareholders face the risk of delisting and potential loss of investment value.
• Employees may experience uncertainty due to the company's financial and regulatory challenges.
• Customers and suppliers may be concerned about the company's stability and future operations.
• Creditors may be more cautious about extending credit to the company.

Next Steps

• Cosmos Health needs to complete the 2023 audit with RBSM LLP.
• The company must file its Form 10-K to avoid potential delisting from NASDAQ.
• The company may need to address any potential legal or regulatory issues arising from KPMG's concerns.

Key Dates

Keywords

auditor, KPMG, RBSM, accounting, audit, financial statements, inventory, third-party vendor, SEC, Form 10-K, delisting